NASDAQ:ADUS Addus HomeCare (ADUS) Stock Forecast, Price & News $90.15 +1.78 (+2.01%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$88.13▼$90.6950-Day Range$80.75▼$114.0252-Week Range$73.65▼$114.99Volume177,036 shsAverage Volume126,524 shsMarket Capitalization$1.46 billionP/E Ratio29.08Dividend YieldN/APrice Target$112.75 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Addus HomeCare MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside25.1% Upside$112.75 Price TargetShort InterestHealthy1.79% of Float Sold ShortDividend StrengthN/ASustainability-0.50Upright™ Environmental ScoreNews Sentiment0.91Based on 12 Articles This WeekInsider TradingSelling Shares$78,810 Sold Last QuarterProj. Earnings Growth12.50%From $3.60 to $4.05 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.07 out of 5 starsMedical Sector24th out of 1,006 stocksHome Health Care Services Industry2nd out of 7 stocks 3.5 Analyst's Opinion Consensus RatingAddus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $112.75, Addus HomeCare has a forecasted upside of 25.1% from its current price of $90.15.Amount of Analyst CoverageAddus HomeCare has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.79% of the float of Addus HomeCare has been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Addus HomeCare has recently decreased by 46.56%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. Previous Next 5.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAddus HomeCare has received a 85.99% net impact score from Upright. The largest positive contribution comes from its "Meaning & joy" impact, which is mostly driven by its "Private hospice care", "Private occupational therapy services", and "Private home care for the elderly" products. See details.Environmental SustainabilityThe Environmental Impact score for Addus HomeCare is -0.50. Previous Next 2.7 News and Social Media Coverage News SentimentAddus HomeCare has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Addus HomeCare this week, compared to 3 articles on an average week.Search InterestOnly 8 people have searched for ADUS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $78,810.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions97.42% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Addus HomeCare are expected to grow by 12.50% in the coming year, from $3.60 to $4.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 29.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.58.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 29.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 128.22.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 2.10. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Addus HomeCare (NASDAQ:ADUS) StockAddus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.Read More Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address ADUS Stock News HeadlinesMay 29, 2023 | msn.comWall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should KnowMay 29, 2023 | finance.yahoo.comWall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should KnowJune 1, 2023 | Vantage Point (Ad)Major Financial Crisis Could Hit AmericaSomething strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs? May 27, 2023 | msn.comOppenheimer Reiterates Addus HomeCare (ADUS) Outperform RecommendationMay 26, 2023 | markets.businessinsider.comOppenheimer Keeps Their Buy Rating on Addus Homecare (ADUS)May 26, 2023 | finance.yahoo.comMedtronic (MDT) to Expand Diabetes Care With New BuyoutMay 26, 2023 | fool.comAddus HomeCare (NASDAQ: ADUS)May 26, 2023 | americanbankingnews.comAddus HomeCare Co. (NASDAQ:ADUS) Sees Large Drop in Short InterestJune 1, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.May 25, 2023 | finance.yahoo.comInvestors in Addus HomeCare (NASDAQ:ADUS) have seen favorable returns of 54% over the past five yearsMay 24, 2023 | finance.yahoo.comAddus HomeCare to Participate in the 2023 Jefferies Healthcare ConferenceMay 24, 2023 | finance.yahoo.comThermo Fisher (TMO) Expands Manufacturing Facility in APACMay 23, 2023 | finance.yahoo.comHere's Why Investors Should Add Zimmer Biomet (ZBH) NowMay 23, 2023 | americanbankingnews.comAddus HomeCare (NASDAQ:ADUS) Downgraded by StockNews.comMay 19, 2023 | finance.yahoo.comAbbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA ApprovalMay 18, 2023 | finance.yahoo.comEdwards Lifesciences' (EW) TAVR Study Outcome FavorableMay 18, 2023 | finance.yahoo.comMedtronic's (MDT) Global Market Share Strong, FX Headwind StaysMay 15, 2023 | americanbankingnews.comAddus HomeCare Co. (NASDAQ:ADUS) Short Interest Up 12.7% in AprilMay 15, 2023 | americanbankingnews.comAddus HomeCare (NASDAQ:ADUS) Upgraded to "Strong-Buy" at StockNews.comMay 11, 2023 | finance.yahoo.comIs Addus HomeCare (ADUS) Stock Undervalued Right Now?May 9, 2023 | finance.yahoo.comHere's Why Addus HomeCare (ADUS) is Poised for a Turnaround After Losing -24.6% in 4 WeeksMay 9, 2023 | finance.yahoo.comAddus HomeCare to Participate in the 2023 RBC Capital Markets Global Healthcare ConferenceMay 5, 2023 | msn.comRaymond James Maintains Addus HomeCare (ADUS) Outperform RecommendationMay 5, 2023 | americanbankingnews.comAddus HomeCare (NASDAQ:ADUS) PT Lowered to $109.00May 5, 2023 | americanbankingnews.comAddus HomeCare (NASDAQ:ADUS) Price Target Cut to $118.00May 4, 2023 | americanbankingnews.comAddus HomeCare Co. (NASDAQ:ADUS) EVP Sean Gaffney Sells 495 SharesMay 3, 2023 | msn.comRBC Capital Maintains Addus HomeCare (ADUS) Outperform RecommendationSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address ADUS Company Calendar Last Earnings10/31/2021Today6/01/2023Next Earnings (Estimated)8/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ADUS CUSIPN/A CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees33,182Year FoundedN/APrice Target and Rating Average Stock Price Forecast$112.75 High Stock Price Forecast$123.00 Low Stock Price Forecast$101.00 Forecasted Upside/Downside+25.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$3.10 Trailing P/E Ratio29.08 Forward P/E Ratio25.04 P/E Growth2.1Net Income$46.03 million Net Margins5.15% Pretax Margin6.63% Return on Equity8.87% Return on Assets5.86% Debt Debt-to-Equity Ratio0.17 Current Ratio1.68 Quick Ratio1.68 Sales & Book Value Annual Sales$951.12 million Price / Sales1.54 Cash Flow$4.23 per share Price / Cash Flow21.32 Book Value$40.04 per share Price / Book2.25Miscellaneous Outstanding Shares16,200,000Free Float15,491,000Market Cap$1.46 billion OptionableOptionable Beta0.89 Key ExecutivesR. Dirk AllisonChairman & Chief Executive OfficerW. Bradley BickhamPresident & Chief Operating OfficerBrian W. PoffCFO, Secretary, Treasurer & Executive VPNick DuthieVice President-Information TechnologyMichael WattenbargerChief Information Officer & Executive VPKey CompetitorsAdaptHealthNASDAQ:AHCOEnhabitNYSE:EHABAmedisysNASDAQ:AMEDOption Care HealthNASDAQ:OPCHDynavax TechnologiesNASDAQ:DVAXView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 200 shares on 5/26/2023Ownership: 0.014%Legato Capital Management LLCSold 1,480 shares on 5/25/2023Ownership: 0.041%Royce & Associates LPBought 3,642 shares on 5/23/2023Ownership: 0.098%Ameriprise Financial Inc.Sold 29,850 shares on 5/22/2023Ownership: 2.559%New York State Common Retirement FundSold 5,390 shares on 5/18/2023Ownership: 0.088%View All Insider TransactionsView All Institutional Transactions ADUS Stock - Frequently Asked Questions Should I buy or sell Addus HomeCare stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ADUS shares. View ADUS analyst ratings or view top-rated stocks. What is Addus HomeCare's stock price forecast for 2023? 4 equities research analysts have issued 12 month price objectives for Addus HomeCare's stock. Their ADUS share price forecasts range from $101.00 to $123.00. On average, they anticipate the company's stock price to reach $112.75 in the next year. This suggests a possible upside of 25.1% from the stock's current price. View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts. How have ADUS shares performed in 2023? Addus HomeCare's stock was trading at $99.49 at the start of the year. Since then, ADUS stock has decreased by 9.4% and is now trading at $90.15. View the best growth stocks for 2023 here. Are investors shorting Addus HomeCare? Addus HomeCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 284,900 shares, a drop of 46.6% from the April 30th total of 533,100 shares. Based on an average daily trading volume, of 154,700 shares, the days-to-cover ratio is currently 1.8 days. Currently, 1.8% of the shares of the stock are sold short. View Addus HomeCare's Short Interest. When is Addus HomeCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023. View our ADUS earnings forecast. How were Addus HomeCare's earnings last quarter? Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $216.66 million for the quarter, compared to the consensus estimate of $227.11 million. Addus HomeCare had a net margin of 5.15% and a trailing twelve-month return on equity of 8.87%. The business's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period last year, the firm posted $0.69 EPS. What ETFs hold Addus HomeCare's stock? ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Argent Mid Cap ETF (AMID), Inspire Fidelis Multi Factor ETF (FDLS), Invesco S&P SmallCap Momentum ETF (XSMO), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), SPDR S&P 600 Small Cap Growth ETF (SLYG) and iShares S&P Small-Cap 600 Growth ETF (IJT). What is Dirk Allison's approval rating as Addus HomeCare's CEO? 91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS). What is Addus HomeCare's stock symbol? Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS." Who are Addus HomeCare's major shareholders? Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.57%), Silvercrest Asset Management Group LLC (4.53%), Wellington Management Group LLP (4.18%), Dimensional Fund Advisors LP (3.84%), Principal Financial Group Inc. (3.84%) and State Street Corp (3.41%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Addus HomeCare's stock price today? One share of ADUS stock can currently be purchased for approximately $90.15. How much money does Addus HomeCare make? Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.46 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $3.10 on an earnings per share basis. How many employees does Addus HomeCare have? The company employs 33,182 workers across the globe. How can I contact Addus HomeCare? Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707. This page (NASDAQ:ADUS) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.